How Real-World Clinico-Genomic Data is Delivering New Cancer Insights
Real-world clinico-genomic data is recognized across the healthcare community as a catalyst to spur potentially life-changing advancements in care and has become instrumental in our joint work to improve outcomes for patients with cancer. By analyzing this data, we can zoom in on niche patient populations to answer questions such as how patients with specific genomic signatures respond to a given treatment.
From the Foundation Forward Blog
December 01, 2021
September 17, 2021
August 26, 2021
August 03, 2021
July 15, 2021